US3998226A
(en)
*
|
1975-09-22 |
1976-12-21 |
Edward G. Gomez |
Inhalation device for encapsulated concentrates
|
US3994421A
(en)
*
|
1975-09-29 |
1976-11-30 |
American Cyanamid Company |
Unitary therapeutic aerosol dispenser
|
SE408265B
(sv)
*
|
1975-12-12 |
1979-06-05 |
Draco Ab |
Anordning for koldioxiddriven endosaerosol, avsedd for inhalering
|
GR69682B
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
*
|
1978-09-11 |
1982-07-08 |
Newhouse Michael T |
|
DE3348370C2
(de)
*
|
1982-10-08 |
2001-10-11 |
Glaxo Group Ltd |
Medikamenten-Packung und Verfahren zur Erzeugung eines zur Inhalation bestimmten Medikamenten-Pulver-Luftstroms
|
IT1217890B
(it)
*
|
1988-06-22 |
1990-03-30 |
Chiesi Farma Spa |
Dispositivo per l'inalazione di aerosol dosati
|
US5169639A
(en)
*
|
1988-09-19 |
1992-12-08 |
Edward Mendell Co., Inc. |
Controlled release verapamil tablets
|
US5040527A
(en)
*
|
1990-12-18 |
1991-08-20 |
Healthscan Products Inc. |
Metered dose inhalation unit with slide means
|
US5186164A
(en)
*
|
1991-03-15 |
1993-02-16 |
Puthalath Raghuprasad |
Mist inhaler
|
US5993805A
(en)
*
|
1991-04-10 |
1999-11-30 |
Quadrant Healthcare (Uk) Limited |
Spray-dried microparticles and their use as therapeutic vehicles
|
US5744123A
(en)
*
|
1991-12-12 |
1998-04-28 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
IL104068A
(en)
*
|
1991-12-12 |
1998-10-30 |
Glaxo Group Ltd |
Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
|
US5658549A
(en)
*
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
US5653962A
(en)
*
|
1991-12-12 |
1997-08-05 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
US5916540A
(en)
*
|
1994-10-24 |
1999-06-29 |
Glaxo Group Limited |
Aerosol formulations containing P134A and/or P227 and particulate medicament
|
US5736124A
(en)
*
|
1991-12-12 |
1998-04-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
US5674471A
(en)
*
|
1991-12-12 |
1997-10-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and salbutamol
|
WO1993011744A1
(en)
*
|
1991-12-12 |
1993-06-24 |
Glaxo Group Limited |
Medicaments
|
AU663906B2
(en)
*
|
1991-12-12 |
1995-10-26 |
Glaxo Group Limited |
Medicaments
|
US7101534B1
(en)
|
1991-12-18 |
2006-09-05 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
ES2159678T3
(es)
|
1991-12-18 |
2001-10-16 |
Minnesota Mining & Mfg |
Formulaciones de aerosol en suspension.
|
US7105152B1
(en)
|
1991-12-18 |
2006-09-12 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
GB9322014D0
(en)
*
|
1993-10-26 |
1993-12-15 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
US5839429A
(en)
*
|
1994-03-25 |
1998-11-24 |
Astra Aktiebolag |
Method and apparatus in connection with an inhaler
|
US5598836A
(en)
*
|
1995-05-26 |
1997-02-04 |
Healthscan Products, Inc. |
Metered dose inhalation unit with slide means
|
US5976573A
(en)
*
|
1996-07-03 |
1999-11-02 |
Rorer Pharmaceutical Products Inc. |
Aqueous-based pharmaceutical composition
|
DE19740617A1
(de)
*
|
1997-09-16 |
1999-03-18 |
Palas Gmbh |
Verfahren und Vorrichtung zum Erzeugen eines Feststoff-Aerosols
|
US6345617B1
(en)
|
1997-09-26 |
2002-02-12 |
1263152 Ontario Inc. |
Aerosol medication delivery apparatus and system
|
US6293279B1
(en)
|
1997-09-26 |
2001-09-25 |
Trudell Medical International |
Aerosol medication delivery apparatus and system
|
CA2733850C
(en)
|
2000-04-11 |
2013-10-22 |
Trudell Medical International |
Aerosol delivery apparatus with positive expiratory pressure capacity
|
CA2445516C
(en)
*
|
2001-04-26 |
2007-11-20 |
New England Pharmaceuticals, Inc. |
Metered dose delivery device for liquid and powder agents
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
US7582284B2
(en)
*
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
US20030205226A1
(en)
*
|
2002-05-02 |
2003-11-06 |
Pre Holding, Inc. |
Aerosol medication inhalation system
|
US6904908B2
(en)
|
2002-05-21 |
2005-06-14 |
Trudell Medical International |
Visual indicator for an aerosol medication delivery apparatus and system
|
WO2005025506A2
(en)
*
|
2003-09-10 |
2005-03-24 |
Map Pharmaceuticals, Inc. |
Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
|
US8365725B2
(en)
*
|
2004-09-13 |
2013-02-05 |
Oriel Therapeutics, Inc. |
Dry powder inhalers that inhibit agglomeration, related devices and methods
|
NL1027255C2
(nl)
*
|
2004-10-15 |
2006-04-19 |
Lab Tickner Ag |
Inrichting voor het verwijderen van een teek.
|
ES2691033T3
(es)
*
|
2007-02-11 |
2018-11-23 |
Map Pharmaceuticals Inc. |
Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios
|
WO2010151804A1
(en)
*
|
2009-06-26 |
2010-12-29 |
Map Pharmaceuticals, Inc. |
Administration of dihydroergotamine mesylate particles using a metered dose inhaler
|
CA156938S
(en)
|
2013-02-14 |
2014-07-08 |
Clement Clarke Int Ltd |
Spacer for an asthma inhaler
|
US10207065B2
(en)
|
2013-07-12 |
2019-02-19 |
John H. Silva |
Mouthpiece for inhalers
|
USD748242S1
(en)
*
|
2014-07-11 |
2016-01-26 |
H. Stuart Campbell |
Inhaler mouthpiece
|
EP4255418A4
(en)
*
|
2020-12-01 |
2025-04-23 |
Reverspah LLC |
METHODS AND COMPOSITIONS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, CHRONIC BRONCHITIS, CYSTIC FIBROSIS, PULMONARY EDEMA, INTERSTITIAL LUNG DISEASE, SARCOIDOSIS, IDIOPATHIC PULMONARY FIBROSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, AND PULMONARY ARTERIAL HYPERTENSION
|